Topics
Glioma | Prognosis | MGMT methylation
Home > Publications > Topics > Glioma > Prognosis > MGMT methylation
Eid M, Alset D, Timoshkina N, Gvaldin D, Rostorguev E, Kavitskiy
S, Novikova I.
IDH mutation and MGMT
methylation status in glioblastoma and other gliomas patients: a
Russian retrospective cohort study.
J
Egypt Natl Canc Inst. 2025 May 16;37(1):36. doi:
10.1186/s43046-025-00296-w. PMID:
40377745. Observational study.
ˍ
Youssef G, Aquilanti E, Miller JJ, Lan Z, Lasica AB,
Arrillaga-Romany I, Batchelor TT, Berger TR, Beroukhim R,
Chukwueke U, Dietrich J, Forst DA, Gerstner ER, Castro LNG, Jordan
JT, Mcfaline-Figueroa JR, Lee EQ, Nayak L, Nakhate V, Ospina JP,
Plotkin SR, Wang N, Rhee JY, Reardon DA, Wen PY.
Prognostic
Significance of MGMT Promoter Methylation Status in IDH-mutant
Glioma.
Neuro
Oncol. 2025 Dec 15:noaf287. doi:
10.1093/neuonc/noaf287. PMID:
41397912. Observational study˰
ˍ